Readystate Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Readystate Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-788,399	Closed	-$46M	–	820
2025 Q4	$42.5M	Buy	+788,399	New	+$37.9M	1.72%	9
2024 Q1	–	Sell	-139	Closed	-$7.08K	–	894
2023 Q4	$7.13K	Buy	+139	New	+$7.3K	﹤0.01%	606
2023 Q3	–	Sell	-7,440	Closed	-$476K	–	501
2023 Q2	$476K	Buy	+7,440	New	+$499K	0.04%	217

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Readystate Asset Management's BMY Position: Q1 2026 in Review

Readystate Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 788,399 shares — an estimated $46M sold.

Readystate Asset Management first reported a position in BMY in Q2 2023 and held it in 3 quarters. The position peaked at $42.5M in Q4 2025. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Readystate Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
Readystate Asset Management sold 788,399 Bristol-Myers Squibb shares in Q1 2026, an estimated $46M.
Readystate Asset Management first reported a position in Bristol-Myers Squibb in Q2 2023 and held it in 3 quarters.
Readystate Asset Management's Bristol-Myers Squibb position peaked at $42.5M in Q4 2025.
2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Readystate Asset Management's 13F filing for Q1 2026, filed 15 May 2026.